GT Biopharma (GTBP) EBITDA (2014 - 2020)
GT Biopharma's EBITDA was $11.02 million in Q4 2020, down 64.8% from $31.29 million a year earlier.
Powered by 
Analysis
GT Biopharma (GTBP) EBITDA (2014 - 2020) Analysis & Trends
For FY2020, EBITDA at GT Biopharma came in at $6.45 million, down 61.1% from FY2019.
- EBITDA shows a five-year compound annual growth rate of 47.8% (FY2015 to FY2020).
- In earlier years, EBITDA was $16.57 million in FY2019, -$241.4 million in FY2018, -$130.65 million in FY2017 and -$6.48 million in FY2016.
- Quarterly EBITDA has moved between -$233.7 million (Q3 2018) and $31.29 million (Q4 2019) over five years.
- Per Business Quant data, GTBP's EBITDA in the three quarters before Q4 2020 was -$1.95 million (Q3 2020), -$1.56 million (Q2 2020) and $1.07 million (Q1 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 7.05 Bn |
| 10 | GT Biopharma | 6.65 Mn | -16.58 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 11.02 Mn |
| Sep 30, 2020 | -1.95 Mn |
| Jun 30, 2020 | -1.56 Mn |
| Mar 31, 2020 | 1.07 Mn |
| Dec 31, 2019 | 31.29 Mn |
| Sep 30, 2019 | -8.74 Mn |
| Jun 30, 2019 | -2.10 Mn |
| Mar 31, 2019 | -3.89 Mn |
| Dec 31, 2018 | -2.24 Mn |
| Sep 30, 2018 | -233.70 Mn |
| Jun 30, 2018 | -966,000.00 |
| Mar 31, 2018 | -4.49 Mn |
| Dec 31, 2017 | -5.77 Mn |
| Sep 30, 2017 | -124.26 Mn |
| Jun 30, 2017 | -1.29 Mn |
| Mar 31, 2017 | 660,000.00 |
| Dec 31, 2016 | 378,000.00 |
| Sep 30, 2016 | -2.34 Mn |
| Jun 30, 2016 | -1.42 Mn |
| Mar 31, 2016 | -3.09 Mn |
API Access
GT Biopharma EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();